中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
2期
64-65
,共2页
胺碘酮%心力衰竭%心律失常%不良反应
胺碘酮%心力衰竭%心律失常%不良反應
알전동%심력쇠갈%심률실상%불량반응
Amiodarone%Heart Failure%Arrhythmia%Adverse Reaction
目的:探讨胺碘酮在对心力衰竭合并心律失常患者实施治疗过程中的临床效果。方法选取2011年10月至2013年10月在我院接受心力衰竭合并心律失常治疗的患者56例为研究对象,所有的患者均给予胺碘酮治疗,对患者的临床治疗效果进行回顾性分析,评价临床治疗的有效性。结果患者治疗之后心率、舒张压、收缩压和QTc 间期等指标均明显优于治疗之前,具有统计学意义(P<0.05);患者治疗的有效率为96.4%;不良反应的发生率为8.9%。结论在对心力衰竭合并心律失常患者实施治疗的过程中,胺碘酮的运用可以提高临床治疗的有效率,减低不良反应的发生,有效的改善患者的各项临床指标,安全性非常高,具有显著的效果,值得临床推广。
目的:探討胺碘酮在對心力衰竭閤併心律失常患者實施治療過程中的臨床效果。方法選取2011年10月至2013年10月在我院接受心力衰竭閤併心律失常治療的患者56例為研究對象,所有的患者均給予胺碘酮治療,對患者的臨床治療效果進行迴顧性分析,評價臨床治療的有效性。結果患者治療之後心率、舒張壓、收縮壓和QTc 間期等指標均明顯優于治療之前,具有統計學意義(P<0.05);患者治療的有效率為96.4%;不良反應的髮生率為8.9%。結論在對心力衰竭閤併心律失常患者實施治療的過程中,胺碘酮的運用可以提高臨床治療的有效率,減低不良反應的髮生,有效的改善患者的各項臨床指標,安全性非常高,具有顯著的效果,值得臨床推廣。
목적:탐토알전동재대심력쇠갈합병심률실상환자실시치료과정중적림상효과。방법선취2011년10월지2013년10월재아원접수심력쇠갈합병심률실상치료적환자56례위연구대상,소유적환자균급여알전동치료,대환자적림상치료효과진행회고성분석,평개림상치료적유효성。결과환자치료지후심솔、서장압、수축압화QTc 간기등지표균명현우우치료지전,구유통계학의의(P<0.05);환자치료적유효솔위96.4%;불량반응적발생솔위8.9%。결론재대심력쇠갈합병심률실상환자실시치료적과정중,알전동적운용가이제고림상치료적유효솔,감저불량반응적발생,유효적개선환자적각항림상지표,안전성비상고,구유현저적효과,치득림상추엄。
Objective To explore the clinical effect of amiodarone in the treatment of heart failure combined with arrhythmia patients.Methods A total of 56 cases of heart failure combined with arrhythmia patients who treated in our hospital from October 201 to October 2013 were selected as the research subjects, and al the patients were treated with amiodarone. A retrospective analysis was conducted to analyze the clinical curative effect, and the clinical treatment effectiveness was evaluated.Results The heart rate, systolic pressure, diastolic pressure and QTc interval of the patients after treatment were better than those before treatment, and the differences were significant(P<0.05); the effective rate was 96.4%, and the incidence of adverse reaction was 8.9%.ConclusionDuring the treatment of heart failure combined with arrhythmia,amiodarone can increase the effective rate of clinical treatment and decrease the incidence of adverse reaction, which can effectively improve the clinical indicators with high safety and significant effect, it is worthy of clinical promotion.